Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Use of Ex Vivo Graft Manipulation and Posttransplant Cyclophosphamide Result in Low GvHD Rates and Acceptable Engraftment after RIC Regimens in Pediatric Mismatched SCT

Peter Lang, MD, Michaela Döring, PD Dr. MD, Anne-Marie Lang, M.Sc., Patrick Schlegel, Dr. MD, Christian M. Seitz, Dr. MD, Robin Fischer, Dr. rer. nat., Ursula Holzer, PD Dr. MD, Ines Brecht, PD Dr. MD, Rupert Handgretinger, MD

Blood (2019) 134 (Supplement_1): 3255.

https://doi.org/10.1182/blood-2019-129654

Published: 2019

Journal Articles

Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles

Christian M. Seitz, MD, Verena Kieble, cand.MD, Clara Illi, cand. MD, Selina Reiter, cand. MD, Stefan Grote, MSc, Joerg Mittelstaet, PhD, Dominik Lock, M.Sc., Andrew Kaiser, PhD, Sabine Schleicher, PhD, Rupert Handgretinger, MD PhD, Peter Lang, MD, Patrick Schlegel, MD

Blood (2018) 132 (Supplement 1): 4543.

https://doi.org/10.1182/blood-2018-99-115630

Published: 2018

Journal Articles

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Blood (2018) 132 (Supplement 1): 603.

https://doi.org/10.1182/blood-2018-99-110599

Published: 2018

Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Blood (2018) 132 (Supplement 1): 604.

https://doi.org/10.1182/blood-2018-99-110124

Published: 2018

Journal Articles

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Karin Melanie Cabanillas Stanchi, MSc, Julia Vek, Dr. MD, Patrick Schlegel, MD, Christian M. Seitz, MD, Joachim Rupprecht, Dr. MD, Sarah Schober, Dr. MD, Sebastian Michaelis, Dr. MD, Carmen Malaval, Dr. MD, Tim Flaadt, Dr. MD, Lukas Schnaufer, Dr. MD, Manon Queudeville, Dr. MD, Judith Feucht, Dr. MD, Peter Lang, MD, Rupert Handgretinger, MD PhD, Michaela Döring, Dr. MD

Blood (2018) 132 (Supplement 1): 3388.

https://doi.org/10.1182/blood-2018-99-112762

Published: 2018

Journal Articles

Procalcitonin and C-Reactive Protein during Transplant-Related Adverse Events after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Karin Melanie Cabanillas Stanchi, MSc, Melinda Eikemeier, Dr. MD, Peter Lang, MD, Rupert Handgretinger, MD PhD, Michaela Döring, Dr. MD

Blood (2018) 132 (Supplement 1): 2102.

https://doi.org/10.1182/blood-2018-99-113865

Published: 2018

Journal Articles

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Michaela Döring, MD, Karin Melanie Cabanillas Stanchi, Manon Queudeville, MD, Judith Feucht, MD, Patrick Schlegel, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Prof. MD, Werner J. Heinz, MD

Blood (2015) 126 (23): 4338.

https://doi.org/10.1182/blood.V126.23.4338.4338

Published: 2015

Journal Articles

Transfer of Ex Vivo Expanded NK and γδT Cells from Untouched Posttransplant PBMCs to Clear Minimal Residual Disease in Acute Myeloid Leukemia

Patrick Schlegel, MD, Chihab Klose, PhD, Christina Kyzirakos, PhD, Ursula J.E. Seidel, Kai Witte, Annika Horrer, Marie Matela, Matthias Pfeiffer, MD, Rupert Handgretinger, Peter Lang, MD

Blood (2014) 124 (21): 5294.

https://doi.org/10.1182/blood.V124.21.5294.5294

Published: 2014

Journal Articles

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Wolfgang Schwinger, MD, Patrick Schlegel, MD, Michael Schumm, DVM, Anne-Marie Lang, Barbara Lang, MD, Carl Philipp Schwarze, MD, Martin Ebinger, MD, Christian E. Urban, MD, Rupert Handgretinger

Blood (2014) 124 (21): 852.

https://doi.org/10.1182/blood.V124.21.852.852

Published: 2014

Journal Articles

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Matthias Pfeiffer, Ingo Mueller, Andre Schrauder, MD, Rupert Handgretinger, Peter Lang, MD

Blood (2013) 122 (21): 4573.

https://doi.org/10.1182/blood.V122.21.4573.4573

Published: 2013

Journal Articles

From Bedside To Bench: Molecular Benchmarking Of An Fc-Optimized CD19 Antibody Used In Treatment Of Relapsed and Refractory Pediatric B-Lineage Acute Lymphoblastic Leukemia

Ursula J.E. Seidel, Ludger Grosse-Hovest, PhD, Patrick Schlegel, MD, Martin Hofmann, Friedhelm R. Schuster, MD, Kai-Erik Witte, Steffen Aulwurm, PhD, Rouwen Teltschik, Elwira Pyz, PhD, Hans-Georg Rammensee, Gundram Jung, MD, Rupert Handgretinger, Prof., Peter Lang, MD

Blood (2013) 122 (21): 3905.

https://doi.org/10.1182/blood.V122.21.3905.3905

Published: 2013

Journal Articles

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Peter Bader, Hermann Kreyenberg, PhD, Arend von Stackelberg, Cornelia Eckert, PhD, Meisel Roland, MD, Pötschger Ulrike, MD, Daniel Stachel, MD, Martin Schrappe, MD, Andre Schrauder, MD, Ansgar Schulz, MD, Peter Lang, MD, Ingo Mueller, MD, Michael H. Albert, MD, Thomas Klingebiel, MD, Christina Peters, MD

Blood (2013) 122 (21): 1995.

https://doi.org/10.1182/blood.V122.21.1995.1995

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Grzegorz W. Basak, MD, PhD, Wieslaw W. Jedrzejczak, MD, PhD, Helene Schoemans, MD, Per T. Ljungman, MD, PhD, Guido Kobbe, MD, Yves Beguin, MD, PhD, Peter Lang, MD, Karl-Walter Sykora, MD, Liane CJ te Boome, MD, Anja van Biezen, Steffie van der Werf, Mohamad Mohty, MD, PhD, Theo de Witte, MD, Judith Marsh, Peter Dreger, MD, Nicolaus Kroeger, MD, Rafael F. Duarte, MD, PhD, Tapani Ruutu, MD PhD

Blood (2013) 122 (21): 2110.

https://doi.org/10.1182/blood.V122.21.2110.2110

Published: 2013

Journal Articles

Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation

Katharina Reinhardt, Dirk Föll, MD, Thomas Vogl, PhD, Falko Fend, MD, Christian Gille, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Wolfgang A. Bethge, MD, Ursula Holzer, MD

Blood (2013) 122 (21): 2058.

https://doi.org/10.1182/blood.V122.21.2058.2058

Published: 2013

Journal Articles

Control Of Allograft Rejection With Mitomycin C Incubated Blood Cells

Johann Greil, MD, Christian Kleist, PhD, Elisabeth Mohr, PhD, Flavius Sandra-Petrescu, PhD, Lucian Jiga, MD, PhD, Laura Dittmar, Venkata Satagopam, PhD, Haydar Demirdizen, Michael Hundemer, MD, Luis Becker, MD, Peter Lang, MD, Gerhard Opelz, MD, Peter Terness, MD

Blood (2013) 122 (21): 4457.

https://doi.org/10.1182/blood.V122.21.4457.4457

Published: 2013

Journal Articles

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Michael Schumm, DVM, Patrick Schlegel, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger

Blood (2013) 122 (21): 692.

https://doi.org/10.1182/blood.V122.21.692.692

Published: 2013

Journal Articles

Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation.

Judith Feucht, Kathrin Opherk, Cornelia Neinhaus, Simone Kayser, Wolfgang A. Bethge, MD, Rupert Handgretinger, MD, Peter Lang, MD, Tobias F. Feuchtinger, MD

Blood (2012) 120 (21): 3047.

https://doi.org/10.1182/blood.V120.21.3047.3047

Published: 2012

Journal Articles

Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia

Peter Lang, MD, Heiko-Manuel Teltschik, MD, Patrick Schlegel, MD, Ursula Seidel, Ludger Grosse-Hovest, PhD, Steffen Aulwurm, PhD, Martin Hofmann, Rouwen Teltschik, Kai Witte, MD, Hans-Georg Rammensee, Prof., Gundram Jung, MD, Rupert Handgretinger, MD

Blood (2012) 120 (21): 581.

https://doi.org/10.1182/blood.V120.21.581.581

Published: 2012

Journal Articles

A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter Lang, MD, Tobias F. Feuchtinger, MD, Patrick Schlegel, MD, Heiko-Manuel Teltschik, MD, Roland Meisel, MD, Friedhelm R. Schuster, MD, Bernd Gruhn, MD, Wolfgang Schwinger, MD, Christian E. Urban, MD, Holger Martinius, Ulrike Pflückhahn, Rouwen Teltschik, Christina Kyzirakos, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2012) 120 (21): 4154.

https://doi.org/10.1182/blood.V120.21.4154.4154

Published: 2012

Journal Articles

Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation

Heiko-Manuel Teltschik, MD, Hanna Kreil, Patrick Schlegel, MD, Tobias F. Feuchtinger, MD, Michael Schumm, DVM, Rupert Handgretinger, MD, Peter Lang, MD

Blood (2012) 120 (21): 4156.

https://doi.org/10.1182/blood.V120.21.4156.4156

Published: 2012

NARROW

Use of Ex Vivo Graft Manipulation and Posttransplant Cyclophosphamide Result in Low GvHD Rates and Acceptable Engraftment after RIC Regimens in Pediatric Mismatched SCT

Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT

Procalcitonin and C-Reactive Protein during Transplant-Related Adverse Events after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Transfer of Ex Vivo Expanded NK and γδT Cells from Untouched Posttransplant PBMCs to Clear Minimal Residual Disease in Acute Myeloid Leukemia

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

From Bedside To Bench: Molecular Benchmarking Of An Fc-Optimized CD19 Antibody Used In Treatment Of Relapsed and Refractory Pediatric B-Lineage Acute Lymphoblastic Leukemia

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation

Control Of Allograft Rejection With Mitomycin C Incubated Blood Cells

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation.

Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia

A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only